TSVT (2seventy Bio) Margin bathi reged

Lambang korporat lan logo 2seventy bio, Inc (TSVT)

Gross margin illustrates the actual production yield, with this metric equaling 41.70. 2seventy bio, Inc. (TSVT) masterfully transforms complex research into approved cellular therapies. The company leads in myeloma therapy through its alliance with BMS and the development of one-time curative treatments. The business relies on a sovereign cycle, rendering the asset a defensive asset independent of macroeconomic trends.

TSVT - Margin reged 2seventy Bio ing rentang 04.07.2022 - 24.05.2025

Rincian metrik komprehensif lan analitis 2seventy Bio (TSVT)

Pambiji fundamental:2seventy bio (TSVT)
Produk sing diprodhuksi 2seventy bio Inc.

Seeking to revolutionize cancer gene therapy, 2seventy bio, Inc. (TSVT) management is optimizing costs associated with the creation of cell products. Gross margin measures the portion of revenue minus direct production costs, stripping operational data of subjective accounting adjustments. Analyzing the gross margin chart allows an investor to assess the real efficiency of the business and avoid purchasing overpriced assets during periods of artificial growth.